Click here to load reader
Upload
buithuy
View
212
Download
0
Embed Size (px)
Citation preview
DAFTAR PUSTAKA
1. Harsono. Kapita Selekta Neurologi Edisi 2. Jogjakarta: Gajah MadaUniversity Press; 2007
2. Rugg-Gunn FJ, Smalls JE. A Practical Guide to Epilepsy: Lecture Notes.Oxford: International League Against Epilepsy; 2015
3. Ngugi AK, Bottemley C, Kleinschmidt I et al. Estimation of the burden ofactive and life-time epilepsy: a meta-analytic approach. Epilepsia 2010;51: 883–90.
4. Sander JW. The epidemiology of epilepsi revisited. Current Opinion inNeurology 2003;16:165-70.
5. Harsono. Buku Ajar Neurologi Klinis. Yogyakarta: Gajah MadaUniversity Press; 2008:119-33
6. Oktaviani F, Khosama H. Epidemiologi Epilepsi. In: Kusumastuti K,Gunadharma S, Kustiowati E, editors. Pedoman Tatalaksana Epilepsi.Surabaya: Airlangga University Press; 2014:1-4
7. WHO. Epilepsi: epidemiology, etiology, and prognosis.WHO Fact SheetNo. 165; 2001
8. Fisher RS, Acevedo C, Arzimanoglou A, et al. A practical clinicaldefinition of epilepsy. Epilepsia 2014; 55:475-82
9. Hovinga, Collin A. et al. Association of non-adherence to antiepilepticdrugs and seizures, quality of life, and productivity: Survey of patientswith epilepsi and physicians. Epilepsi & Behavior. 2008;13(2):316-22
10. Maryanti NCW. Epilepsi dan budaya. Buletin Psiklogi. 2016;24(1):23-32
11. Ginsberg, Lionel. Lecture Notes Neurologi Edisi Kedelapan. Jakarta:Penerbit Erlangga; 2009.h.79-87
12. Yerbi MS. Quality of life, epilepsy advances, and the evolving role ofanticonvulsants in women with epilepsy. Neurology. 2000;55(5):21-31
13. O’Donoghue. Assessing the psychosocial consequences of epilepsy: acommunity-based study.British Journal of General Practice. 1999;49:211-14
14. Tomson, T. Compliance with Antiepileptic Drug Treatment and the Riskof SUDEP. In: Lathers CM, Schraeder PL, editors. Sudden Unexpected
http://repository.unimus.ac.id
Death in Epilepsy: Mechanisms and New Method for Analyzing Risks.New York: CRC Press; 2015:297-300
15. Markam, Soemarmo. Penuntun Neurologi. Tangerang: Binarupa Aksara.2009
16. Kusmastuti K, Basuki M. Definisi, klasifikasi dam etiologi epilepsi. In:Kusumastuti K, Gunadharma S, Kustiowati E, editors. PedomanTatalaksana Epilepsi. Surabaya: Airlangga University Press; 2014: 14-8
17. Shorvon, SD. The etiologic classification of epilepsy. Epilepsia 2011;52(6):1052-7
18. Munir, Badrul. Neurologi Dasar. Jakarta: Sagung Seto; 2015: 174-79
19. Harsono. Epilepsi Edisi Kedua. Yogyakarta: Gadjah Mada UniversityPress; 2007
20. Browne TR, Holmes GL. Handbook of Epilepsy Fourth Edition.Philadelphia: Lippincott Williams & Wilkins; 2008
21. Utama, Hendra. Antiepilepsi dan Antikonvulsi. In: Farmakologi danTerapi Edisi 5. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2011
22. Gunadharma S, Kustiowati E, Husna M . Terapi. In: Kusumastuti K,Gunadharma S, Kustiowati E, editors. Pedoman Tatalaksana Epilepsi.Surabaya: Airlangga University Press; 2014. p.30
23. Faught E, Richman J, Martin R, et al. Incidence and prevalence of epilepsiamong older US Medicare beneficiaries. Neurology. 2012;78(7):448-53.
24. Eatock J, Baker JA. Managing patient adherence and quality of life inepilepsy. Neuropsychiatric Disease and Treatment. 2007:3(1) 117–31
25. WHO. Adherence To Long-Term Therapies: Evidence for action; 2003
26. Pascal AM, Rush SE, Sadler T. Factors associated with medicationadherence in patients with epilepsy and recommendations forimprovement. Epilepsy & Behavior. 2014;31:346-50
27. Morisky DE, DiMatteo MR. Improving the measurement of self-reportedmedication nonadherence: Final response. Journal of ClinicalEpidemiology. 2011;64: 258-63
http://repository.unimus.ac.id
28. WHOQOL Group. Development of the World Health OrganizationWHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551-58.
29. Hörnquist JO. The concept of quality of life. Scand J Soc Med.1982;10(2):57-61.
30. Loring DW, Meador KJ, Lee GP. Determinants of quality of life epilepsy.Epilepsy & Behavior. 2004;5(6):976-80
31. St Louis, EK. Minimizing AED Adverse Effects: Improving Quality ofLife in the Interictal State in Epilepsy Care. Current Neuropharmacology.2009;7(2):106-14
32. Choi-Kwon, S., Chung, C., Kim, H., Lee, S., Yoon, S., Kho, H., Oh, J. andLee, S. Factors affecting the quality of life in patients with epilepsy inSeoul, South Korea. Acta Neurologica Scandinavica.2003.108:428–34
33. Harsono. The quality of life of epileptic patients. Universa medicina. 2008;27:194-203
34. Ashari. Perbandingan Kualitas Hidup Pasien Epilepsi Lobus TemporalYang Bebas Kejang Dengan Yang Tidak Bebas Kejang PascaAmigdalohippokampektomi. [Skripsi]. Semarang: UniversitasDiponegoro; 2012
35. Geoge J, Kullkarni C, Sarma GRK. Antiepileptic Drugs and Quality ofLife in Patients with Epilepsy: A Tertiary Care Hospital-Based Study.Value in Health Regional Issues. 2015;6:1-6
36. St Louis, EK. Minimizing AED Adverse Effects: Improving Quality ofLife in the Interictal State in Epilepsy Care. Current Neuropharmacology.2009;7(2):106-14
37. Thomas SV, Koshy S, Sudhakaran Nair C R, Sarma SP. Frequent seizuresand polytherapy can impair quality of life in persons with epilepsy. NeurolIndia. 2005;53:46-50
38. Schimdt D, Gramm L. Monotherapy versus Polytherapy in Epilepsy: AReappraisal. CNS Drugs. 1995;3(3):194-208
39. Privitera, M. Ficker DM. Assessment of adverse events and quality of lifein epilepsy: design of a new community-based trial. Epilepsy & Behavior.2004;5: 841–46
http://repository.unimus.ac.id
40. Abdelrahim MA, Dafaala MD, Alfaki MM, et al. Association ofmedications adherence with the quality of lifeand cost of epilepsy amongSudanese epilepsy patients attending charity clinic. Journal of theNeurological Sciences. 2015;357: 30-2
41. Christensen J, Kjeldsen MJ, Andersen H, Friis ML, Sidenius P. Genderdifferences in epilepsy. Epilepsia. 2005 Jun 1;46(6):956-60.
42. Hawari I, Syeban Z, Lumempouw SF. Low education, more frequent ofseizure, more types of therapy, and generalized seizure type decreasedquality of life among epileptic patients.Med J Indones. 2007; 16:101-3
http://repository.unimus.ac.id